# Mriglobal

Canonical: https://abierto.us/vendors/mriglobal-hkqhnfknkl15

- UEI: HKQHNFKNKL15
- CAGE: 21165
- Location: Kansas City, MO
- Awards in window: 47 (137 transactions), $79,808,280 obligated, January 15, 2025 to September 10, 2026

## Awarding agencies

- National Institutes of Health: 32 awards, $29,541,863
- Department of the Air Force: 3 awards, $27,973,643
- Environmental Protection Agency: 1 awards, $13,813,179
- Washington Headquarters Services: 1 awards, $5,268,830
- Office of Procurement Operations: 1 awards, $1,854,583
- Departmental Offices: 1 awards, $739,894
- Office of Assistant Secretary for Preparedness and Response: 3 awards, $369,640
- U.S. Secret Service: 1 awards, $240,343
- Centers for Disease Control and Prevention: 1 awards, $10,000
- Department of the Army: 1 awards, $0
- Federal Acquisition Service: 1 awards, $0
- Defense Contract Management Agency: 1 awards, -$3,694

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): $32,687,667
- 541690 Other Scientific and Technical Consulting Services: $15,405,340
- 336211 Motor Vehicle Body Manufacturing: $13,813,179
- 541712 Professional, Scientific, and Technical Services: $6,396,962
- 541380 Testing Laboratories and Services: $5,519,173
- 325412 Pharmaceutical Preparation Manufacturing: $3,172,150
- 541714 Research and Development in Biotechnology (except Nanobiotechnology): $2,805,184
- 325411 Medicinal and Botanical Manufacturing: $476,573
- 332311 Prefabricated Metal Building and Component Manufacturing: $299,593
- 541711 Professional, Scientific, and Technical Services: -$767,541

## Competition

- Full and Open Competition: 43 awards
- Not Competed: 2 awards
- Not Competed Under SAP: 1 awards
- Competed Under SAP: 1 awards

## Solicitations won

- Analytical Services Center for Medications Development Program (75N98026D00031), $5,000,000. https://abierto.us/opportunities/75n98026d00031
- JOFOC: 68HERH25C0005:Portable High Throughput Integrated Laboratory Identification Systems (PHILIS) Platform Modernization, Change Order (68HERH25C0005), $13,038,279. https://abierto.us/opportunities/68herh25c0005
- Diagnostic Test Development and Production for Emergency Response (75D30125D20639), $148,000,000. https://abierto.us/opportunities/75d30125d20639
- The purpose of this requirement is to contract for API and Diluent (140D0425Q0704). https://abierto.us/opportunities/140d0425q0704

## Largest awards

- FA807524F0027 (delivery order): $27,791,965, FA8075 774 Ess. Information Analysis Center Multiple Award Contract Task Order Performance Work Statement (Pws) Research, Development, Test and Evaluation for the Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense. https://www.usaspending.gov/award/CONT_AWD_FA807524F0027_9700_FA807518D0017_9700/
- 68HERH25C0005 (definitive contract): $13,813,179, Headquarters Acquisition Div. Portable High Throughput Integrated Laboratory Identification Systems (Philis) Platform Modernization 2.0. https://www.usaspending.gov/award/CONT_AWD_68HERH25C0005_6800_-NONE-_-NONE-/
- 75N91023F00001 (delivery order): $10,910,576, NIH NCI. Centralized Chemopreventive Agent Repository and Chemistry Support. https://www.usaspending.gov/award/CONT_AWD_75N91023F00001_7529_75N91023D00010_7529/
- HHSN273201400020C (definitive contract): $6,396,962, National Institute of Health Niehs. Contract Extension, Exercise OP12. https://www.usaspending.gov/award/CONT_AWD_HHSN273201400020C_7529_-NONE-_-NONE-/
- HQ003422C0090 (definitive contract): $5,268,830, Washington Headquarters Services. Chemical, Biological, Radiological and Nuclear Laboratory Support Services. https://www.usaspending.gov/award/CONT_AWD_HQ003422C0090_9700_-NONE-_-NONE-/
- 75N91025F00001 (delivery order): $3,460,074, NIH NCI. Manufacture of Clinical Grade Epstein-Barr Virus Vaccine. https://www.usaspending.gov/award/CONT_AWD_75N91025F00001_7529_75N91023D00010_7529/
- 70RWMD23C00000023 (definitive contract): $1,854,583, CWMD Acq Div. Doge Cost Efficiency Eo Exclusion Section 2(D). the Purpose of This Modification Is to Rescope the Statement of Work to Include Replacing the Principal Investigator with Joseph A. Russell at No Cost to the Government.. https://www.usaspending.gov/award/CONT_AWD_70RWMD23C00000023_7001_-NONE-_-NONE-/
- 75N93024C00002 (definitive contract): $1,771,765, National Institutes of Health Niaid. Mycobacterium Tuberculosis (Mtb) Quality Assessment Program (Tbqa). https://www.usaspending.gov/award/CONT_AWD_75N93024C00002_7529_-NONE-_-NONE-/
- 75N93026F00003 (delivery order): $1,571,051, National Institutes of Health Niaid. Performing FDA 510K Enabling Studies for a Diagnostic to Detect Ciprofloxicin Resistance or Susceptability. https://www.usaspending.gov/award/CONT_AWD_75N93026F00003_7529_75N93023D00017_7529/
- 75N98026F00002 (delivery order): $1,363,408, National Institutes of Health Olao. Ninds' Drug Manufacturing and Formulation Program (Dmfp): Shamloo-Selective CB2 Agonist; MRI Research INC:1186811 [26-000042]. https://www.usaspending.gov/award/CONT_AWD_75N98026F00002_7529_75N98026D00014_7529/
- 75N91024F00002 (delivery order): $1,266,044, NIH NCI. Manufacture of Plasmid Dna Drug Substance and Drug Product. https://www.usaspending.gov/award/CONT_AWD_75N91024F00002_7529_75N91023D00010_7529/
- 75N95023F00001 (delivery order): $1,108,033, National Institutes of Health Nida. Slaugenhaupt-Mgh DMFP for BPN36964 (PTC680). https://www.usaspending.gov/award/CONT_AWD_75N95023F00001_7529_HHSN271201500006I_7529/
- 75N93026F00002 (delivery order): $787,684, National Institutes of Health Niaid. Diagnostics Pre-Clinical Services Program. https://www.usaspending.gov/award/CONT_AWD_75N93026F00002_7529_75N93023D00017_7529/
- 140D0425P0205 (purchase order): $739,894, Ibc Acq SVCS Directorate. The Purpose of This Requirement Is to Contract for Api and Diluent. https://www.usaspending.gov/award/CONT_AWD_140D0425P0205_1406_-NONE-_-NONE-/
- 75N98026F00002 (delivery order): $478,052, National Institutes of Health Olao. Phase 1 Single Ascending Dose Pharmacokinetics Study: Parent/Metabolite(S). Analytical Services Center for Medications Development. July 20, 2026 - January 19, 2028. Task Order 02. Dap-Ncap-00000009. https://www.usaspending.gov/award/CONT_AWD_75N98026F00002_7529_75N98026D00031_7529/
- 75N95024F00002 (delivery order): $437,278, National Institutes of Health Nida. Exercise Options 1,2,3,4. https://www.usaspending.gov/award/CONT_AWD_75N95024F00002_7529_75N95024D00012_7529/
- 75N98026F00001 (delivery order): $382,839, National Institutes of Health Olao. Phase 1 Single Ascending Dose Pharmacokinetics Study. Analytical Services Center for Medications Development. July 20, 2026 - January 19, 2028. Task Order 01. Dap-Ncap-00000009. https://www.usaspending.gov/award/CONT_AWD_75N98026F00001_7529_75N98026D00031_7529/
- 75N98026F00001 (delivery order): $369,210, National Institutes of Health Olao. This Task Order Is to Provide Regulatory Support for Vaginitis PCR Assay.. https://www.usaspending.gov/award/CONT_AWD_75N98026F00001_7529_75N93023D00017_7529/
- 75A50226C00001 (definitive contract): $299,593, Aspr/Daappo/Orm HQ. Portable Biocontainment Units (Pbcus) - Ebola Response 2026. https://www.usaspending.gov/award/CONT_AWD_75A50226C00001_7505_-NONE-_-NONE-/
- 70US0926F3OTH3091 (bpa call): $240,343, U. S. Secret Service. Biological Countermeasures BPA Call Order #3 - T&e Services. https://www.usaspending.gov/award/CONT_AWD_70US0926F3OTH3091_7009_70US0921A70090039_7009/
- 75N93022F00001 (delivery order): $230,480, National Institutes of Health Niaid. Eoi::{radical Transparency About Wasteful Spending}::eoi{bilateral Modification to Descope}. https://www.usaspending.gov/award/CONT_AWD_75N93022F00001_7529_75N93022D00002_7529/
- FA807521F0020 (delivery order): $181,678, FA8075 774 Ess. Research, Development, Test, Evaluation, and Strategic Initiatives for Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense. https://www.usaspending.gov/award/CONT_AWD_FA807521F0020_9700_FA807518D0017_9700/
- 75N91023F00001 (delivery order): $158,581, NIH NCI. Evaluation of Shelf-Life of Samples of Investigational Clinical Drug Formulations, to Include Parenteral, Oral, and Other Types of Dosage Forms.. https://www.usaspending.gov/award/CONT_AWD_75N91023F00001_7529_75N98019D00061_7529/
- 75A50123F61001 (delivery order): $70,047, Barda - Aspr / Daappo / Barda DCMA. Bio-Amt-2301: IDIQ Contract Management Support Activities. https://www.usaspending.gov/award/CONT_AWD_75A50123F61001_7505_75A50122D00018_7505/
- 75N95022F00001 (delivery order): $39,295, National Institutes of Health Nida. ML-246 (Metarrestin) Stability Studies. https://www.usaspending.gov/award/CONT_AWD_75N95022F00001_7529_HHSN271201700006I_7529/
- 75D30125D20639: $10,000, CDC Office of Acquisition Services. Diagnostic Testing IDIQ. https://www.usaspending.gov/award/CONT_IDV_75D30125D20639_7523/
- 75N93026F00001 (delivery order): $7,192, National Institutes of Health Niaid. Regulatory Support for Software as Medical Device (Samd) for Next-Gen Sequencing Id Analysis. https://www.usaspending.gov/award/CONT_AWD_75N93026F00001_7529_75N93023D00017_7529/
- 75A50323C00031 (definitive contract): $0, Aspr/Orm-Sns. The Contractor Shall Be Capable of Completing All Necessary Design, Fabrication, Testing, and Delivery of All Biocontainment Units.. https://www.usaspending.gov/award/CONT_AWD_75A50323C00031_7505_-NONE-_-NONE-/
- 75N91024F00001 (delivery order): $0, NIH NCI. The Scope of This Task Order Is (1). Production of a Drug Substance, (2) Conversion of Drug Substance to Drug Product, (3) Filling Drug Product Into Applicators to Be Used in the Clinical Trials, and (4) Production of a Placebo Product.. https://www.usaspending.gov/award/CONT_AWD_75N91024F00001_7529_75N91023D00010_7529/
- 47QRCA25DU229: $0, Gsa/Fas/Pshc/Oasis Plus. One Acquisition Solution for Integrated Services Plus (Oasis+) Unrestricted Multiple Agency Contract (Mac). https://www.usaspending.gov/award/CONT_IDV_47QRCA25DU229_4732/
- 75N91023D00007: $0, NIH NCI. Eo 14398 Analysis and Synthesis of GMP and NON-GMP Bulk Drugs and Pharmaceutical Formulations. https://www.usaspending.gov/award/CONT_IDV_75N91023D00007_7529/
- 75N91023D00010: $0, NIH NCI. IDIQ Contract for Centralized Chemopreventive Agent Repository and Chemistry Support Services. https://www.usaspending.gov/award/CONT_IDV_75N91023D00010_7529/
- 75N93021D00041: $0, National Institutes of Health Niaid. The Purpose of This Modification Is to Revise Section J. List of Attachments, Item 1. Statement of Work. the Revision Removes Language Limiting Support to the National Institute of Allergy and Infectious Diseases (Niaid) and Expands the Scope of the. https://www.usaspending.gov/award/CONT_IDV_75N93021D00041_7529/
- 75N93022D00002: $0, National Institutes of Health Niaid. EO14398 the Contractor Shall Provide Niaid with a Broad and Flexible Range of Capabilities That Are Required for Preclinical and Translational Development Support for Promising Vaccines and Related Products for Hiv and Other Candidate Agents.. https://www.usaspending.gov/award/CONT_IDV_75N93022D00002_7529/
- 75N95024D00012: $0, National Institutes of Health Nida. Eo 14398 Idiq: Chemistry, Manufacturing and Controls and Related Services for Development of Drug Substances. https://www.usaspending.gov/award/CONT_IDV_75N95024D00012_7529/
- 75N95024D00022: $0, National Institutes of Health Nida. Safety Evaluation and Toxicology Studies and Related Services for Drug Development. https://www.usaspending.gov/award/CONT_IDV_75N95024D00022_7529/
- 75N98026D00014: $0, National Institutes of Health Olao. Ninds Drug Manufacturing and Formulation Program (Dmfp). https://www.usaspending.gov/award/CONT_IDV_75N98026D00014_7529/
- 75N98026D00031: $0, National Institutes of Health Olao. Analytical Services Center for Medications Development. Single Award R&D IDIQ Contract. July 20, 2026 - July 19, 2031. Dap-Ncap-00000009. https://www.usaspending.gov/award/CONT_IDV_75N98026D00031_7529/
- FA807518D0017: $0, FA8075 774 Ess. Department of Defense Information Analysis Center Multiple Award Contract. https://www.usaspending.gov/award/CONT_IDV_FA807518D0017_9700/
- W911QY18D0115: $0, W6QK ACC-APG Natick. Research, Development, Acquisition and Procurement of Chemical, Biological, Radiological and Nuclear Defense Systems. https://www.usaspending.gov/award/CONT_IDV_W911QY18D0115_9700/
- N6600121C4048 (definitive contract): -$3,694, DCMA Great Lakes. Undefinitized Order. https://www.usaspending.gov/award/CONT_AWD_N6600121C4048_9700_-NONE-_-NONE-/
- 75N98020F00001 (delivery order): -$5,666, National Institutes of Health Olao. Idp Production for the Ketamine Program-Quote # NIH-OLAO 0001. https://www.usaspending.gov/award/CONT_AWD_75N98020F00001_7529_75N98019D00061_7529/
- HHSN27100001 (delivery order): -$7,607, National Institutes of Health Nida. To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2020 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2025, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_HHSN27100001_7529_HHSN271201500006I_7529/
- 75N95019F00088 (delivery order): -$13,931, National Institutes of Health Nida. To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2020 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2025, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_75N95019F00088_7529_HHSN271201500006I_7529/
- HHSN261201800003C (definitive contract): -$170,562, NIH NCI. Drug Shelf Life Testing Period of Performance 02/01/2023 - 07/31/2023. https://www.usaspending.gov/award/CONT_AWD_HHSN261201800003C_7529_-NONE-_-NONE-/
- 75N91019F00129 (delivery order): -$231,354, NIH NCI. Centralized Chemopreventive Agent Repository and Chemistry Support. https://www.usaspending.gov/award/CONT_AWD_75N91019F00129_7529_75N91018D00026_7529/
- HHSN272201700001C (definitive contract): -$767,541, National Institutes of Health Niaid. To Administrate De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in Preparation for September 30, 2026, Closing of the Period of Availability of These Fiscal Year Funds.. https://www.usaspending.gov/award/CONT_AWD_HHSN272201700001C_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/mriglobal-hkqhnfknkl15.